Significance of molecular technology in diagnosis and therapy of non-small-cell lung cancer.
10.3760/cma.j.issn.0529-5807.2012.08.017
- Author:
Xiao-xia CHEN
;
Cai-cun ZHOU
- Publication Type:Journal Article
- MeSH:
Adenocarcinoma;
diagnosis;
drug therapy;
genetics;
metabolism;
Antineoplastic Agents;
therapeutic use;
Carcinoma, Non-Small-Cell Lung;
diagnosis;
drug therapy;
genetics;
metabolism;
Carcinoma, Squamous Cell;
diagnosis;
drug therapy;
genetics;
metabolism;
DNA-Binding Proteins;
genetics;
metabolism;
Discoidin Domain Receptors;
Glutamates;
therapeutic use;
Guanine;
analogs & derivatives;
therapeutic use;
Humans;
Lung Neoplasms;
diagnosis;
drug therapy;
genetics;
metabolism;
Molecular Diagnostic Techniques;
methods;
Mutation;
Oncogene Proteins, Fusion;
genetics;
metabolism;
Pemetrexed;
Protein Kinase Inhibitors;
therapeutic use;
Proto-Oncogene Proteins B-raf;
genetics;
metabolism;
Receptor Protein-Tyrosine Kinases;
genetics;
metabolism;
Receptor, Epidermal Growth Factor;
antagonists & inhibitors;
genetics;
metabolism;
Receptors, Mitogen;
genetics;
metabolism;
Transcription Factors
- From:
Chinese Journal of Pathology
2012;41(8):570-572
- CountryChina
- Language:Chinese
